← Eichor
Condition: Hpv Cancers Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hpv Cancers

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts
Phase 2 · 1 location(s) · Zagazig University · NCT05291845High Resolution Anuscopy Study
Phase N/A · 1 location(s) · Universitair Ziekenhuis Brussel · NCT06697964HPV After chemoRadioTherapy
Phase N/A · 1 location(s) · General University Hospital, Prague · NCT07493928HPV-based Screening Among Women 23-29 Years of Age
NA · 2 location(s) · Karolinska Institutet · NCT05229679Pocket Colposcopy Using CARE Algorithm
NA · 1 location(s) · Duke University · NCT06458062Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · 153 location(s) · NRG Oncology · NCT06532279Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes
Phase 2 · 1 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06640283Normalizing Antibody Detection in First-void Urine
Phase N/A · 1 location(s) · Universiteit Antwerpen · NCT06582654Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT04988074Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
Phase N/A · 3 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT04564989The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)
Phase 2 · 2 location(s) · Icahn School of Medicine at Mount Sinai · NCT05419089Breast Cancer-Related Approach for Increasing Cervical Cancer Screening
NA · 1 location(s) · Jessica Di Vincenzo Sormani · NCT07171658De-escalation of Adjuvant Radiation for Low-Risk HPV Oropharyngeal Cancers
NA · 1 location(s) · Georgetown University · NCT06554158Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Phase 2 · 3 location(s) · Mayo Clinic · NCT05541016Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Phase N/A · 1 location(s) · Viome · NCT05451303Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Ind
Phase N/A · 1 location(s) · Massachusetts Eye and Ear Infirmary · NCT06744296Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
Phase 2 · 1 location(s) · Medical University of South Carolina · NCT07513389BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or S
Phase 2 · 225 location(s) · National Cancer Institute (NCI) · NCT05136196Microvideos for Improving HPV Vaccination Among Childhood Cancer Survivors
NA · 1 location(s) · University of Utah · NCT07648953Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel
Phase 2 · 1 location(s) · KTH Biopharma · NCT07698886Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings
NA · 1 location(s) · National Healthcare Group Polyclinics · NCT06528184Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
NA · 3 location(s) · University of California, Irvine · NCT07209917PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia
Phase 2 · 10 location(s) · PapiVax Biotech, Inc. · NCT07454915Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05026138Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell Carcino
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06161545Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07209189HPV Genotype Attribution and Disease Burden of Anal Cancer in China
Phase N/A · 1 location(s) · Fudan University · NCT06670495Multicenter Real-World Study of Hyperthermia in Warts of Special Population
NA · 1 location(s) · First Hospital of China Medical University · NCT06827938Feasibility Study of Ocular Surface Squamous Neoplasia Surgical Excision in People Living With HIV in Sub-Saharan Africa
NA · 1 location(s) · AIDS Malignancy Consortium · NCT04704648
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.